Online citations, reference lists, and bibliographies.
← Back to Search

Survival Of Malignant Mesothelioma And Other Rare Thoracic Cancers In Germany And The United States: A Population‐based Study

E. Sirri, J. Kieschke, C. Vohmann, A. Katalinic, A. Nennecke, M. Ressing, A. Eberle, B. Holleczek, L. Jansen, H. Brenner
Published 2020 · Medicine

Save to my Library
Download PDF
Analyze on Scholarcy
Evidence on survival of malignant mesothelioma (MM) and other rare thoracic cancers is limited due to the rarity of these cancer sites. Here, we provide a comprehensive overview of MM incidence and survival after MM and other rare thoracic cancers in Germany and the United States (US). Incidence was estimated from a German National Cancer Database and from the Surveillance, Epidemiology and End Results (SEER) 18 database for 2000–2014. Patients diagnosed in 1997–2013 with malignant epithelial tumors of the trachea (Etra), epithelial tumors of the thymus (Ethy) and MM were extracted from a German cancer survival database and from the SEER 13 database. Period analysis was employed to compute 5‐year relative survival (RS). During 2000–2014, an annual average of 0.9 and 0.6 MM cases per 100,000 person‐years was diagnosed in Germany and the US. Rates decreased in Germany and in the US. Patients with Ethy had highest 5‐year RS with US patients surviving longer (69.1% compared to 63.7%, p = 0.02). Survival after Etra was comparable in both countries (Germany 33.6%, US 34.4%, p = 0.07). Survival in MM patients was poor overall (Germany 11.8%, US 12.1%, p < 0.01). Survival improvements were only observed in MM patients in Germany (10.8% [2002–2007] vs. 13.0% [2008–2013], p < 0.01). The lack of progress in survival for Etra and Ethy patients underlines the need of novel preventive, therapeutic and diagnostic approaches. MM incidence significantly decreased in Germany and in the US. Further monitoring of MM incidence is warranted given that a peak in incidence is expected in 2020–2030 in Western countries.
This paper references
Tumors that mimic asbestos-related mesothelioma: time to consider a genetics-based tumor registry?
B. Kerger (2014)
Standard cancer patient population for age standardising survival ratios.
I. Corazziari (2004)
Mesothelioma: recent highlights.
M. Carbone (2017)
The effect of multiple primary rules on population-based cancer survival
H. Weir (2013)
F. Marletta (1891)
Marital status is an independent prognostic factor for tracheal cancer patients: an analysis of the SEER database
M. Li (2016)
Cancer Incidence in Five Continents
Freddie Ian Bray (1970)
Thymoma: A population-based study of the management and outcomes for the province of British Columbia.
C. Mariano (2011)
Relative survival
B. D'amato (2014)
Mesothelioma and thymic tumors: Treatment challenges in (outside) a network setting.
M. Imbimbo (2019)
Smoking prevalence and attributable disease burden in 195 countries and territories, 1990–2015: a systematic analysis from the Global Burden of Disease Study 2015
Marissa B Nancy Marie Joseph S Amanuel Kalkidan Hassen Cri Reitsma Fullman Ng Salama Abajobir Abate Abbafati (2017)
Differential Expression of Ki-67 and Sex Steroid Hormone Receptors Between Genders in Peritoneal Mesothelioma
Terence C. Chua (2009)
a systematic analysis from the Global Burden of Disease Study
of Health and Human Services
U. S Departmen (2018)
How ageing processes influence cancer
J. P. Magalhães (2013)
Survival of pleural malignant mesothelioma in Italy: A population‐based study
F. Montanaro (2009)
Cytoplasmic 5′-3′ exonuclease Xrn1p is also a genome-wide transcription factor in yeast
D. A. Medina (2014)
Thymic epithelial tumors: a clinicopathologic study of 249 cases from a single institution.
Xue-ying Su (2014)
Preventable exposures associated with human cancers.
V. Cogliano (2011)
Recent cancer survival in Germany: An analysis of common and less common cancers
L. Jansen (2015)
Primary tracheal malignant neoplasms: the University of Texas MD Anderson Cancer Center experience.
B. D. Webb (2006)
Management and prognosis of primary tracheal cancer: A national analysis
S. Mahmoud Nouraei (2014)
Treatment Results and Prognostic Indicators in Thymic Epithelial Tumors: A Clinicopathological Analysis of 45 Patients
M. Ansari (2014)
Surveillance, Epidemiology, and End Results (SEER) program research data
Up-to-date long-term survival curves of patients with cancer by period analysis.
H. Brenner (2002)
A computer program for period analysis of cancer patient survival.
H. Brenner (2002)
Statistical Methodology and Applications Branch, Surveillance Research Program
Estrogen receptor-beta affects the prognosis of human malignant mesothelioma.
G. Pinton (2009)
Survival from common and rare cancers in Germany in the early 21st century.
E. Hiripi (2012)
National Asbestos Profile for Germany, 1. edn. Dortmund: Bundesanstalt für Arbeitsschutz und Arbeitsmedizin
Deriving Valid Population–Based Cancer Survival Estimates in the Presence of Nonnegligible Proportions of Cancers Notified by Death Certificates Only
H. Brenner (2011)
Overview of malignant tracheal tumors.
M. Madariaga (2018)
SEER) Program SEER*Stat database: incidence-SEER 18 Regs research data+Hurricane Katrina impacted Louisiana cases
Epidemiology Surveillance (2000)
Instructions to IBM 650 programmers in processing survival
F Ederer (1959)
Reduction of population-based cancer survival estimates by trace back of death certificate notifications: an empirical illustration.
B. Holleczek (2012)
2020 The Authors
Importance of gender in diffuse malignant peritoneal mesothelioma.
C. Cao (2012)
Global mesothelioma epidemic: Trend and features
C. Bianchi (2014)
Up-to-date and precise estimates of cancer patient survival: model-based period analysis.
H. Brenner (2006)
Sex difference in diffuse malignant peritoneal mesothelioma
T. Yan (2006)
Rare thoracic cancers, including peritoneum mesothelioma.
S. Siesling (2012)
Asbestos bodies in lung tissue are associated with pathologic features and patient outcome for epithelial but not non-epithelial mesothelioma treated by extrapleural pneumonectomy
W. Richards (2009)
Malignant Pleural Mesothelioma: A Population-Based Study of Survival
M. Milano (2010)
Instructions to IBM 650 programmers in processing survival computations
F Ederer (1959)
Association of Population-based Cancer Registries in Germany (GEKID): Cancer incidence and mortality atlas in Germany., data update
Full dates (day, month, year) should be used in population‐based cancer survival studies
L. Woods (2012)
Characteristics of malignant pleural mesothelioma in women.
A. Wolf (2010)
Poor prognosis in elderly patients with cancer: the role of bias and undertreatment.
D. Dale (2003)
Surveillance Research Program, National Cancer Institute SEER*Stat software. Version 8.3.5 www.
Mesothelioma incidence in 50 states and the District of Columbia, United States, 2003–2008
S. Jane Henley (2013)
Population Based Cancer Registry Analysis of Primary Tracheal Carcinoma
A. Urdaneta (2011)
Determinants and interpretation of death certificate only proportions in the initial years of newly established cancer registries.
H. Brenner (2013)
Center for Cancer Registry Data: www.krebsdate. de/abfrage; Data submission
Relative survival rate.
J. M. Bae (2004)
Projecting SEER cancer survival rates to the US: an ecological regression approach
A. Mariotto (2004)

This paper is referenced by
Semantic Scholar Logo Some data provided by SemanticScholar